Cage; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cage; Peter.The latest application filed is for "piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them".

Company Profile

0.4.10

Cage; Peter - Loughborough GB
Cage; Peter - Leicestershire GB
Cage, Peter - Shepshed GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperidines as chemokine modulators (CCR) Grant 7,956,070 - Alcaraz , et al. June 7, 2	2011-06-07
Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090197914 - Cage; Peter ; et al.	2009-08-06
Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090023733 - Cage; Peter ; et al.	2009-01-22
Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090012125 - Cage; Peter ; et al.	2009-01-08
Medicaments App 20080108661 - Cage; Peter ; et al.	2008-05-08
Novel piperidines as chemokine modulators (ccr) App 20070054924 - Alcaraz; Lilian ; et al.	2007-03-08
Pyrimidine compounds and their use as modulators of chemokine receptor activity Grant 6,958,344 - Bonnert , et al. October 25, 2	2005-10-25
Thiazolopyrimidines and their use as modulators of chemokine receptor activity Grant 6,958,343 - Bonnert , et al. October 25, 2	2005-10-25
Pyrimidine compounds and their use as modulators of chemokine receptor activity App 20050234077 - Bonnert, Roger ; et al.	2005-10-20
Novel compounds App 20040214864 - Cage, Peter ; et al.	2004-10-28
Pyrimidine compounds and their use as modulators of chemokine receptor activity App 20030040523 - Bonnert, Roger ; et al.	2003-02-27
Thiazolopyrimidines and thier use as modulators of chemokine receptor activity App 20030032642 - Bonnert, Roger ; et al.	2003-02-13
Novel compounds App 20020086862 - Baxter, Andrew ; et al.	2002-07-04
Biologically active benzothiazolone ethanamines Grant 5,929,100 - Bonnert , et al. July 27, 1	1999-07-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.